Activated oxazaphosphorines are transported predominantly by erythrocytes

M.S. Highley; D. Schrijvers; A.T. van Oostrom; P.G. Harper; G. Momerency; K. van Cauwenberghe; R.A.A. Maes; E.A. de Bruijn; M.B. Edelstein

Activated oxazaphosphorines are transported predominantly by erythrocytes

M.S. Highley, D. Schrijvers, A.T. van Oostrom, P.G. Harper, G. Momerency, K. van Cauwenberghe, R.A.A. Maes, E.A. de Bruijn, M.B. Edelstein

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1139-1144
Number of pages	6
Journal	Annals of Oncology
Volume	8
Publication status	Published - 1997

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Public Health
Analytical chemistry
Drugmisbruik en verslaving

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{6642def0f792401aadbda960e1627154,

title = "Activated oxazaphosphorines are transported predominantly by erythrocytes",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Public Health, Analytical chemistry, Drugmisbruik en verslaving",

author = "M.S. Highley and D. Schrijvers and \{van Oostrom\}, A.T. and P.G. Harper and G. Momerency and \{van Cauwenberghe\}, K. and R.A.A. Maes and \{de Bruijn\}, E.A. and M.B. Edelstein",

year = "1997",

language = "Undefined/Unknown",

volume = "8",

pages = "1139--1144",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Activated oxazaphosphorines are transported predominantly by erythrocytes

AU - Highley, M.S.

AU - Schrijvers, D.

AU - van Oostrom, A.T.

AU - Harper, P.G.

AU - Momerency, G.

AU - van Cauwenberghe, K.

AU - Maes, R.A.A.

AU - de Bruijn, E.A.

AU - Edelstein, M.B.

PY - 1997

Y1 - 1997

KW - Medical technology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Public Health

KW - Analytical chemistry

KW - Drugmisbruik en verslaving

M3 - Article

SN - 0923-7534

VL - 8

SP - 1139

EP - 1144

JO - Annals of Oncology

JF - Annals of Oncology

ER -